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ABSTRACT OF THE THESIS

The Challenges of Applying Computational Legal Analysis
to mHealth Security and Privacy Regulations
by
Brian Beyuan Tung
Master of Science in Computer Science
Washington University in St. Louis, August 2021
Research Advisor: Professor Ning Zhang

As our world has grown in complexity, so have our laws. By one measure, the United
States Code has grown over 30x as long since 1935, and the 186,000-page Code of Federal
Regulations has grown almost 10x in length since 1938. Our growing legal system is too
complicated; it’s impossible for people to know all the laws that apply to them. However,
people are still subject to the law, even if they are unfamiliar with it. Therein lies the need
for computational legal analysis. Tools of computation (e.g., data visualization, algorithms,
and artificial intelligence) have the potential to transform civic education, legal procedure,
and society at large. In this thesis, I try to apply computation to a small part of the law,
federal regulations and recommendations about mHealth security and privacy, and explain
why I believe legal computation can lead to more equitable health outcomes. I conclude that
the open-ended nature of the law, the FDA’s reliance upon self-certification, and complicated
legal dependencies make it difficult to apply computation to mHealth security and privacy
regulation. However, the use of non-legal, authoritative guidance documents that explain
regulatory intent may aid in the development of computational legal auditors.

viii

Chapter 1
Introduction
It is difficult to overstate the importance of the law in our society. The law affects every
aspect of our lives, and as much as technologists like to deny it, our current technological
environment is a direct product of our legal system. Our laws, and the government described
therein, encode the rules of society we all must follow. Our current technologies depend on
their legal protections for their existence. Patents, trade secrets, copyright, national security,
civil rights, international commerce, data sharing, and free speech are just a few legal areas
that are of interest to technologists. Agencies that enforce how the law is applied are also
important; for example, the continued success of free software licenses like the GPL are
entirely dependent on legal systems that respect, and have the power to enforce, the GPL’s
copy-left conditions.
As society has gotten more complicated, however, the law has also ballooned in complexity.
In 1935, the U.S. Code was roughly 2,500 pages, but in 2020 the U.S. Code was over 30x
as long at roughly 80,000 pages [38, 125].1 The Code of Federal Regulations (C.F.R.), a
compilation of the rules posited by executive departments and agencies, likewise continues
to grow. In 1938, its first release, the C.F.R. was around 20,000 pages. In 2019, the C.F.R.
was a staggering 186,000 pages [12]. Furthermore, new judicial decisions come out regularly,
which when combined with all previous existing judicial decisions, comprise U.S. case law.
1

The measurement of the law is an active research area. I readily acknowledge that measuring page-length
is an imperfect way to measure the length of the law, and I discuss this measurement issue later in this
thesis. Many measurement issues remain active research questions; for example, we don’t know how many
laws there are, how to measure how long the law is, or how to measure legal complexity [11, 107, 33, 79,
32, 100, 112, 160].
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Our federalist system, where governing authority is shared among the federal, state, county,
city, and even neighborhood levels, further complicates legal issues.
The law seems too complicated! It’s impossible for any person to know all the laws that
apply to her. And yet in the event of a transgression “ignorance of the law excuses not”
or ignorantia juris non excusat. The law still applies, even if the transgressor is unaware
of its existence. With the ballooning complexity of our government and legal systems, our
society desperately needs innovation in civic education. It’s our moral duty to help people
understand the laws that govern our lives.
In light of this problem, my thesis asks the broad question: can computation help people
understand the law? Specifically, I investigate the two questions: (1) can we teach computers
to understand the law, and (2) can we automate checking for legal compliance.

1.1

Can We Teach Computers to Understand the Law?

As I previously mentioned, the law has gotten too complicated. In 1935, the U.S. Code was
roughly 2,500 pages, but in 2020 it is over 30x as long, at roughly 80,000 pages [38, 125].
The Code of Federal Regulations (C.F.R.), a compilation of the rules posited by executive
departments and agencies, likewise continues to grow. In 1938 the C.F.R. was around 20,000
pages, but in 2019 it was a staggering 186,000 pages [12]. The U.S. Code, the compilation
and organization of legislative laws, is separate from regulations from executive agencies,
compiled in the Code of Federal Regulations, which is separate from the vast repository of
case law that also comprises U.S. law. Complicating things further, the law is constantly
changing. Yet, people are still bound by the law, whether or not they understand it.
In response to this problem, my first question asks: is there a way to represent the law in
such a way that computers can understand it? If so, we’d be able to harness the power of
computation in our scholarship, practice, and civic education.

2

1.2

Can We Automate Checking for Legal Compliance?

If we can combine the art of legal analysis with the power of computation, tools like data
visualization, AI, UI/UX, human-computer interaction, and algorithms may be applied to
the legal field as well. While simply synthesizing the law into a format understandable by
computers is important, the next part of my thesis investigates the possibility of automatically interpreting the law as applied to a specific situation. In other words, the second
part of my thesis investigates the ability of a layperson to ask questions like: “does my app
violate HIPAA regulations”, or “can my doctor share my medical history with a company
without notifying me”. These personalized questions more closely represent the kinds of
legal questions that are of interest to laypeople.

1.3

How this Thesis is Organized

This thesis begins by giving some key background on the U.S. government and legal system.
Then, because trying to teach computers to understand all areas of the law is too broad,
I narrow the scope of my investigation to pursue a case-study in mobile health (mHealth)
security and privacy regulation. This case study is motivated by the belief that by teaching
computers to automatically audit mHealth security and privacy regulations, we can ultimately encourage equitable mHealth adoption and reduce inequalities in healthcare. To
make this argument, I present a theoretical model of technology adoption, directly tied to
one’s trust in technology.
I then investigate if it is possible to automate compliance checking given existing mHealth
security and privacy regulations. I conclude that it would currently be very difficult to do so
and discuss key regulatory characteristics that make it difficult for computers to understand
and audit legal regulations. However, I also find that the use of non-legal, authoritative
guidance documents that explain regulatory intent may help in the creation of computational
legal auditors. I then discuss other work related to computational legal analysis and finish
by giving some recommendations for future study.

3

Chapter 2
Background: U.S. Government &
Legal System
Before we can study how to make the law interpretable to computers, we must first be
familiar with the basics of the U.S. government and legal system.

2.1

Common Law vs. Civil Law

One of the most important distinctions among legal systems are whether they are predominantly influenced by common law or civil law. While most legal systems (including the
U.S.’s) are somewhat of a blend of common, civil, or other types of law, the United States is
often seen as a classic example of common law. Other examples of predominantly common
law states include Canada, the United Kingdom, Ireland, Australia, New Zealand, and India.
Predominantly civil law systems include many other states like a large majority of Europe
and South America, Russia, China, Japan, and South Korea [126, 123].
The most important difference between common and civil law systems is the different roles of
the judicial branch and the legislature. In civil law systems, generally only legislative action
can “update the law”. Therefore, judicial decisions generally only apply to the involved
parties. A judge facing a similar problem, with different parties, does not need to follow a
similar, previous ruling. However, the distinguishing factor of common law is stare decisis
– the doctrine of the legal precedent. In common law systems, once a judge rules on a
4

Figure 2.1: Common vs. Civil Law Adoption.
Figure from JuriGlobe at the University of Ottawa [123]
legal problem, all adequately similar future legal problems are expected to be resolved in the
same way. Only a more powerful court can overrule a lower court’s legal precedent (e.g., the
Supreme Court of the United States can overrule legal precedents made by the U.S. District
Court for the Southern District of New York) [17, 7, 96].
Case law, the aggregation of judicial decisions and their precedents, is vital to the governance
of any common law jurisdiction. The large amount of previous and current judicial opinions,
however, can make it difficult to interpret the law in common law systems [144, 98].
As an example of the importance of case law in the governance of American society, I list
a few historically important judicial cases: Marbury v. Madison (1803), the judicial branch
can strike down laws they find unconstitutional; Dred Scott v. Sandford (1857), slavery is
legal, and slaves are not U.S. citizens; Plessy v. Ferguson (1896), racial segregation is legal;
United States v. Wong Kim Ark (1898), children born in the U.S. have birthright citizenship;
Brown v. Board of Education (1954), racial segregation in public schools is illegal; Roe v.
Wade (1973), abortions are generally legal within the first two trimesters; U.S. v. Windsor
(2013), the federal government must recognize same-sex marriage, overturns part of the 1996
Defense Against Marriage Act; and Obergefell v. Hodges (2015), legalizes same-sex marriage
5

in all states [113, 34, 166, 6, 157, 145, 137]. Note how judicial opinions can change over time
and how future opinions can directly overturn previously established precedents.
Judicial decisions have also had an important impact on technology; a few examples include:
Bernstein v. United States (1996), software code is protected free speech, and encryption
software can be freely shared; Reno v. ACLU (1997), strengthens “free speech” protections
of web content; Zeran v. America Online, Inc. (1997), strengths CDA 230, no provider of a
computer service is held liable for how users use the service; Perfect 10, Inc. v. Amazon.com,
Inc. (2007), image search engines do not violate copyright law; and Carpenter v. United
States (2019), police must get a warrant to access historical cell site location data [78, 136,
106, 114, 105, 154].
These judicial decisions are just a few of the critical opinions that form U.S. law. Those
familiar with U.S. history and recent events ought to know the importance of the judicial
branch in governing American society. The importance of case law in the U.S. legal system
must be underscored, especially for those who are unfamiliar with common law societies.

2.2

Federalism

Another distinctive aspect of the United States is federalism. Federalism is the practice of
sharing power between a national (i.e., federal) government and local governments. These
local governments (e.g., each individual state in the U.S.) often have constitutionally protected sovereignty and powers. The United States is often cited as a canonical example of
federalism and one of the first countries to experiment with federalism on a national scale
[23, 90].
Federalism is often compared to the unitary state, a system in which the central government
exerts more control over local governments. These local governments often do not have constitutionally protected sovereignty, and central governments, if they so choose, may abolish
or override these local governments. France is often thought of as a canonical example of a
unitary state [120, 23].
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Federalism is also compared to confederalism, a system in which local governments trump
more general, centralized governments. The first government of the United States, under the
Articles of Confederation, had many characteristics of confederalism [29, 119]. The European
Union is another example of confederalism, as it balances both federalism with confederalism
in a system sometimes called a “federal union of states” [104, 42, 84].
While the United States is often a canonical example of federalism, and France a canonical example of a unitary state, most countries share federalist and unitary characteristics.
Nonetheless, like the difference between common vs. civil law states, countries can often be
categorized as primarily federalist or unitary. States that are primarily federalist include:
the United States, Canada, Mexico, Germany, Spain, Brazil, Argentina, South Africa, India, Pakistan, Russia, the United Arab Emirates, and Australia. Unitary states primarily
comprise of the rest of the world and a majority of the world’s population.

Figure 2.2: Federalist vs. Unitary States.
Figure from The Forum of Federations Handbook of Federal Countries (2020) [86]
The United States, with its strong system of federalism, complicates our legal analysis. Because it is not always clear what powers are delegated to the federal government and what
powers are delegated to the states, federalism remains one of the most basic, unresolved,
contentious areas of debate and research in America. Furthermore, some of the most controversial topics in America today (like abortion, gun control, voting, and COVID restrictions)
revolve around federalism.
7

If our goal is to computationally analyze the current state of the law, we must not only
be able to analyze federal, state, county, and city laws, but also be able to interpret when
federal laws should trump local laws, and vice versa. Furthermore, each state has its own
body of case law (recall the section: Common Law vs. Civil Law ), somewhat independent
from federal case law. For each given legal situation, it can be difficult to determine the
relationship between relevant federal and state case law.
The analysis of legal questions reminds me of Moravec’s paradox, summed up in this tidy
xkcd cartoon. Like in computer science, some legal questions are fairly simple. However,
other seemingly simple legal questions may be deceptively difficult. In the United States, a
canonical common law and federalist society, legal questions may be especially difficult to
resolve.

Figure 2.3: Moravec’s Paradox.
Image from xkcd [169]
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Chapter 3
An Applied Example: Automated
Auditing of mHealth Security and
Privacy Regulations can Increase
Trust and Reduce Inequalities in
Healthcare
While this thesis is broadly concerned with the application of computation to legal analysis,
the task of teaching computers to understand and reason about all areas of the law is too
broad in scope for my thesis. Therefore, I focus on a narrow application of computational
legal analysis; I study if it is possible to teach computers to understand the privacy and
security regulations for mobile health (mHealth) applications. I chose this narrow subsection
of the law because I believe computational understanding of mHealth security and privacy
regulations can ultimately improve the quality and equity of our healthcare system. This
section gives an example of how computational legal analysis can have a significant, practical
impact on the population at large.

9

3.1

Why mHealth?

mHealth applications have been lauded for their potential to provide cheap, effective, and
personalized healthcare to large groups of people. Medical professionals are optimistic that
mHealth adoption can increase access to high-quality healthcare and improve public health
[94, 165, 31]. Patients are similarly optimistic, hoping that mHealth will improve affordability, convenience, and the quality of healthcare they will receive [151]. In a survey taken
near the beginning of the COVID-19 pandemic, almost half of Americans reported they
were users of an mHealth application [153]. The COVID-19 pandemic further accelerated
mHealth adoption; during the first year of the pandemic mHealth app downloads surged by
over 50% worldwide [152].
mHealth is also important because it presents us with an opportunity to increase equitable
outcomes in healthcare. Current healthcare disparities in the United States and around the
world are well documented [14, 140, 122, 95, 15, 97]. Experts hope that the low-cost and accessibility of mHealth applications can improve health outcomes in underserved communities
[158, 35, 149, 115].
Despite this optimism, or perhaps because of it, others have been quick to point out that
mHealth applications may exacerbate existing healthcare inequalities. Previous research
on technology inequality shows that society’s most vulnerable have the lowest technology
adoption rates and are disproportionally harmed by new technologies [109, 110]. Effective
mHealth applications, if only adopted by the healthiest and most privileged members of
society, may increase health disparities.
Recent research supports the assertation that mHealth applications may be disproportionately benefiting society’s most privileged, while leaving the most vulnerable members of
society behind [24, 150, 41, 8]. Organizations have taken notice, and are actively studying
how to tackle health disparities within mHealth [43, 164].
My investigation of the mHealth regulatory landscape is motivated by my belief that by
automating a firm’s or the FDA’s ability to check an application’s compliance with FDA
regulations, we can ultimately improve the equitable adoption of mHealth applications. To
make this argument, I contribute a novel model of technology adoption that explicitly links
10

technology adoption to trust in the technology itself. This trust is predicated on many
factors, among which include the security and privacy of the application. The ability to
efficiently check if an application satisfies the FDA’s security and privacy regulations will
ultimately improve public trust in and the adoption of mHealth.
This mHealth case study is just one narrow example of how bringing computation to legal
analysis can directly benefit ordinary people.

3.2

A Trust-Based Model for Technology Adoption

mHealth technologies are new and not evenly adopted by the population. If we are trying
to equitably increase mHealth adoption, we need a theory for technology adoption. Here, I
put forward my own trust-based model for technology adoption. This model is adapted from
a theory Lawfare’s Benjamin Wittes gave in a 2021 lecture at Duke University’s Sanford
School of Public Policy, in conversation with Professor David Hoffman, Intel’s associate
general counsel and global privacy officer [93].
Notice that the first layer of my model lists key characteristics that contribute to technology
adoption. Trust is vitally important, and I elaborate on why trust matters for technology
adoption in a later section. Because my analysis focuses on why trust is important and
how computational auditing of FDA regulations can improve trust, I skim over the other
characteristics of my model. These other characteristics are:
1. Momentum – people are reluctant to change usage patterns. For example, Facebook,
Instagram, and WhatsApp usage in the EU remains high, though trust is low, and
alternatives exist (e.g., Signal, Telegram). The continued use of old, unpatched software
is another example of technological momentum.
2. Market Conditions – economic conditions influence adoption. For example, Huawei
products are used in countries even when public trust is low because of their competitive
price.
3. Access – people cannot adopt new technology if they cannot access it. For example,
global demand for mRNA COVID-19 vaccines far outpace supply.
11

12
Figure 3.1: A Trust-Based Model for Technology Adoption

4. Other – other factors not directly covered by the model. For example, specific government rules, regulations, and requirements.

3.2.1

How Security Affects Trust

My model includes two ways to build trust, each of which require two necessary conditions.
All four of these areas are ultimately affected by security and privacy.

Trust in Oneself
The first way to build trust is to have trust in one’s own first-hand experiences. For example,
it is well established that many minorities experience racism in our healthcare system. These
experiences result in greater medical mistrust and lower patient engagement [103, 148, 167].
Those who have experienced medical racism and distrust the medical industry may also mistrust mHealth applications. On the other hand, those who have only had positive experiences
with the medical industry may be especially trusting of mHealth applications.
Another example is that victims of ransomware may need to see stricter assurances that their
data will be protected from hackers before feeling comfortable with mHealth. Recall Vastaamo, the Finnish psychotherapy company whose hack became public knowledge in 2020.
In a shocking and cruel move, criminals posted thousands of patient’s private psychotherapy
notes online [139, 13, 89]. Those who have been the victim of security and privacy violations
in the past may require extra reassurance that their security and privacy will be protected
in an mHealth application.

Trusted Intermediary
If we don’t have any first-hand experience with a new technology, we can still rely on the
experiences and wisdom of trusted intermediaries. These people or organizations may have
first-hand experience with this technology or be in a better position to judge the technology’s
merits.
13

Relying on someone else’s judgement is not a new concept. A traditional example of this kind
of trust relationship exists in our public key infrastructure, in which users must ultimately
trust their certificate authorities. However, these trust networks are also common in other
areas of everyday life. For example, we trust aerospace and medical manufactures to make
safe products. We also trust government entities (like the Federal Aviation Administration
and the Food and Drug Administration) to certify the safety of these products. Trusted
authority figures (e.g., experts, religious and community leaders), journalists, friends, and
social groups may also weigh-in on new technology.
mHealth applications (or other technologies) with strong security and privacy practices can
eventually build a strong reputation throughout one’s network of trusted intermediaries. In
this case, even if one has not used an mHealth application, other people one trusts may have
used the application and can vouch for its trustworthiness.

Theoretically Effective
For an application to establish trust through first-hand experiences or through trusted intermediaries, it is necessary for this application to be theoretically effective. This means that,
in theory, an application or technology can meet the demands of its users.
Health insurance is a good example of the necessity of this theoretical requirement. Health
insurance is predicated on the belief that purchasing health insurance is a good idea, even
when one is healthy. This belief, regardless of whether it’s right or wrong, is necessary for
the health insurance industry. If only those seeking expensive healthcare procedures sought
out health insurance, insurers would not be able to spread out healthcare costs among many
people.
An example closer to mHealth applications is that individuals must believe that mHealth
apps can protect their sensitive health data. If people had absolutely no confidence in an
app’s privacy and security, this application would be unable to inspire confidence through
first-hand experiences or trust networks.
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Practically Effective
Finally, applications and new technologies must also be effective in practice. This means
that applications must satisfy user demands in practice, not only in theory.
Again, health insurance is a good example of the difference between theoretical effectiveness
and practical effectiveness. Not only must people believe that health insurance is a good idea
when they’re healthy (theoretical effectiveness), health insurance must actually be reliable
when a person is in need (practical effectiveness). If someone’s health insurance consistently
refuses to insure their medical expenses, they might lose faith in the theoretical effectiveness
of health insurance. This loss of faith and bad experience directly affects either one’s firsthand experiences (trust in oneself) or the experiences of a trusted intermediary.
In the mHealth security and privacy sphere, practical effectiveness is required to convince
patients that their private medical data can be safely entrusted to mHealth applications.
Even if patients believe that it is theoretically possible to create an mHealth app that
safely guards their medical information, if mHealth apps are regularly leaking personal data,
patients may view mHealth apps with suspicion. Failures to protect medical data may
directly affect a patient (trust in oneself) or affect someone in their trust network (via a
trusted intermediary).

3.2.2

Computational Auditing of mHealth Security and Privacy
Regulations Can Build Trust

I believe that computational auditing of mHealth security and privacy regulations can improve both necessary conditions required to build trust. If these regulations truly do improve
the security and privacy of mHealth applications, the existence of these regulations may
convince people that mHealth applications can theoretically meet their security and privacy
demands.
The ability to enforce these regulations at scale through computational auditing would also
improve mHealth’s privacy and security in practice. Applications that fail federal privacy
and security requirements would be prevented from entering the market, ensuring that all
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mHealth applications meet minimum privacy and security guarantees, allowing apps to be
“effective in practice”.
Furthermore, a computational audit would require the operationalization of mHealth privacy
and security requirements. Therefore, firms with failed mHealth applications could be told
what specific operationalized requirements they failed. By identifying specific points of
improvement, this auditing process would allow firms to quickly fix their mistakes and build
more private and secure applications.
Because computational auditing can help mHealth applications improve their theoretical and
practical effectiveness, patients may be more willing to try out these applications. Other
people’s positive experiences with mHealth apps can improve the reputation of these applications in one’s network of trusted intermediaries. Finally, if one is convinced that an
mHealth app is theoretically effective, effective in practice, and trusted by one’s network,
one may be willing to test out the mHealth app oneself, resulting in first-hand experiences.
These experiences, if positive, further increase trust in the application.
This improved trust, then, encourages the adoption of mHealth technologies, and is especially
important for groups with lower health outcomes and greater medical mistrust.
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Chapter 4
Can We Automatically Check if
mHealth Applications Satisfy Security
and Privacy Regulations?
To study if we can apply the tools of computation to legal analysis, I narrowed my focus to
a small subsection of our legal landscape – the regulation of mHealth applications. This narrower focus dovetails nicely with my host lab, as one research area in my lab is the security
and privacy of mHealth devices. In my thesis, instead of looking for new classes of vulnerabilities in existing mHealth applications, or evaluating defenses for existing vulnerabilities, I
ask a different question – can we create an automated test to detect if mHealth apps satisfy
current regulations for security and privacy?
To answer this question, we must first be able to identify what are the current mHealth
regulations for security and privacy.
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4.1

Background: Federal Rules, Regulations, and Recommendations for mHealth Security and Privacy

If we wish to design cybersecurity tests that are compatible with federal rules, regulations,
and recommendations, it is imperative to be familiar with these federal guidelines. Therefore, I give a high-level overview of the federal regulatory landscape. My overview is not
comprehensive; I limit my analysis to the federal U.S. regulatory environment. Other important non-federal regulations that mHealth apps may be subject to, like state-based biometric
identification laws [138] or California’s Consumer Privacy Act, are considered out-of-scope
of this analysis. Federal case law is similarly considered out-of-scope.

4.1.1

mHealth Apps Inherit The Existing Device Regulatory Framework

The FDA regulatory framework generally treats mHealth apps like traditional medical devices. Importantly, if an mHealth app does not meet the definition of a medical device, its
general effectiveness is not regulated by the FDA (though it is still subject to other laws,
like those related to fraud) [64]. An mHealth app is a medical device when it meets the definitions in the FD&C Act in 21 U.S.C. § 321(h): a medical device is “intended for use in the
diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention
of disease, in man or other animals, or intended to affect the structure or any function of
the body of man or other animals” and does not include the software functions excluded in
21 U.S.C. § 360j(o). These software functions include a handful of exceptions; one notable
exception is that software with an intended use of “maintaining or encouraging a healthy
lifestyle and is unrelated to the diagnosis, cure, mitigation, prevention, or treatment of a disease or condition” is not considered a medical device. The FDA provides numerous resources
to help developers determine if their mHealth app is a medical device. If an application is
not a medical device, the FDA does not regulate its effectiveness [64, 44, 45, 66].
Even if an mHealth app is recognized as a medical device by the FDA, the FDA may choose
to not regulate low-risk apps by exercising “enforcement discretion.” This means that the
FDA may regulate the app in the future, but does not intend to right now, as the “FDA
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intends to apply its regulatory oversight to only those software functions that are medical
devices and whose functionality could pose a risk to a patient’s safety if the device were to
not function as intended” [66]. To determine if an mHealth app that is a medical device
will be regulated by the FDA, one can reference Appendix B of the guidance document
titled “Policy for Device Software Functions and Mobile Medical Applications” [66], view
the FDA’s online resources [44], or contact the FDA directly.
Medical devices are further sorted by their risk and functionality. Class I devices are low
risk and may not require a premarket 510(k) notification. Class II devices are moderate
risk, may have special controls, and often require a premarket 510(k) notification. Class
III devices are high risk, are strictly regulated, and require a premarket approval (PMA)
[69, 53, 67]. Additionally, the FDA assigns all devices a device type, based on the device’s
functionality (e.g., blood pressure alarm, electrocardiograph software for over-the-counter
use). These device types may be found in 21 C.F.R. § 800-1050 and are searchable online
[75]. In the Code of Federal Regulations each device type is described, classified as a Class
I-III device, and given special controls (if applicable). Medical devices must satisfy all the
FDA regulations for their device type, regardless if they are an mHealth app or a traditional
medical device. Manufacturers can ask the FDA to formally classify their device by filing a
513(g) request [63]. Manufacturers with a medical device that does not fit into an existing
device type can ask the FDA to create a new device type through a De Novo request, an
alternative to premarket 510(k) notification and premarket approval (PMA) [61].
Finally, all devices are subject to FDA General Controls. These controls include regulations pertaining to Establishment Registration (21 C.F.R. Part 807), Medical Device Listing
(21 C.F.R. Part 807), Premarket Notification 510(k) (21 C.F.R. Part 807 Subpart E) or
Premarket Approval (PMA) (21 C.F.R. Part 814), Investigational Device Exemption (IDE)
(21 C.F.R. Part 812), Quality System Regulation (QS Regulation) (21 C.F.R. Part 820),
Labeling (21 C.F.R. Part 801), and Medical Device Reporting (21 C.F.R. Part 803).
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4.1.2

Cybersecurity Specifics for mHealth

Many regulations that affect medical devices also affect their cybersecurity, as cybersecurity
involves all parts of the technology stack. Nevertheless, some key principles affecting mHealth
application developers include:

1. The FDA splits cybersecurity risks into two categories: acceptable (“controlled”) risks,
and unacceptable (“uncontrolled”) risks. To determine if a risk is acceptable or unacceptable, manufacturers must consider the exploitability of the vulnerability and the
severity of patient harm if the vulnerability is exploited. Manufacturers are required
to mitigate unacceptable risks either by controlling them entirely or by reducing them
to become acceptable risks. Manufacturers then have to document any residual acceptable risks and explain why they only pose a “sufficiently low” risk of patient harm.
There is some flexibility when defining acceptable and unacceptable risks; the FDA
guidance document “Postmarket Management of Cybersecurity in Medical Devices”
provides further guidance [56].
2. mHealth application manufacturers are required to manage the cybersecurity risk of
their entire application throughout the lifecycle of the app. This requirement is more
difficult than it appears, as it requires application manufacturers to manage cybersecurity risks of “off-the-shelf” software (e.g., open-source software, proprietary third-party
software). Manufacturers may also be required to provide the FDA with “continuity
plans” that address how the manufacturer will handle no-longer supported “off-theshelf” software. [65, 4, 56, 49].
3. There may be regulatory hurdles when trying to patch cybersecurity vulnerabilities.
Generally, vulnerabilities that present controlled risks can be fixed without making substantial changes to the device. However, if an update consists of “substantial changes”
or could “significantly affect the safety or effectiveness” of the device, the manufacturer
may need to re-submit a premarket submission (e.g., PMA Supplement, 510(k)) to the
FDA. [56, 48, 52, 57, 50].
4. Device manufacturers may be required to notify the FDA upon discovery of an uncontrolled cybersecurity risk. Reporting requirements depend on the device’s class and
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type. Generally, vulnerabilities that present only a “controlled risk of patient harm”
do not need to be reported to the FDA. [56, 55, 52].

Most FDA cybersecurity guidance is general advice. However, a 2018 draft guidance titled
“Content of Premarket Submissions for Management of Cybersecurity in Medical Devices”
contains more specific technical recommendations [60]. The FDA also recommends the moretechnical NIST “Framework for Improving Critical Infrastructure Cybersecurity” [118].

4.1.3

Demystifying the U.S.C., C.F.R., and FDA Guidance Documents

When learning about federal guidelines for mHealth cybersecurity, the FDA often cites the
United States Code, the Code of Federal Regulations, and FDA Guidance Documents. It is
important to understand what these publications are and how they relate to one another.
The United States Code (U.S. Code or U.S.C.) is a codification of the current laws passed by
the legislative branch of the United States. The U.S. Code contains 53 Titles and is organized
by subject; for example, Title 21 of the U.S.C. generally covers the laws applicable to food
and drugs. The Food, Drug, and Cosmetic Act (FD&C Act), which gives the FDA many
of its powers, is housed within Chapter 9 of 21 U.S.C. To keep the U.S.C. up-to-date, new
main editions of the U.S.C. are published every six years by the legislative branch of the
U.S. government, with annual cumulative supplements published in-between main editions.
The Code of Federal Regulations (C.F.R.) is the official codification of the rules and regulations promulgated by departments and agencies of the executive branch of the United States.
While laws in the U.S.C. give executive bodies (like the FDA) their powers, the C.F.R. describes how these bodies choose to exercise their powers. Accordingly, it is published by
the executive branch of the U.S. government. One well-known example of the C.F.R. is the
Health Insurance Portability and Accountability Act of 1996 (HIPAA). While the laws that
comprise HIPAA are scattered throughout the U.S.C., the rules that describe what HIPAA
means to the public are located in Title 45 of the C.F.R. Part 160, Part 162, and Part 164.
The official C.F.R. is updated annually, though there is an unofficial online version (e-CFR)
that is updated daily.
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FDA Guidance Documents often explain, elaborate, or complement parts of the C.F.R. These
documents describe the FDA’s current thinking about topics under its authority, including
how the FDA plans to regulate (or not regulate) mHealth applications. It’s important to note
that these guidance documents are only recommendations, with the exception of sections
that cite specific regulatory or statutory requirements. However, these documents offer
invaluable advice; for example, those who are required to submit their mHealth application
for premarket evaluation should familiarize themselves with what the FDA says to include
in premarket submissions. These guidance documents cover many topics, and all 2,500+
guidance documents are searchable online [76].

4.1.4

Labeling Requirements for mHealth Applications

mHealth labeling requirements are not significantly different from labeling requirements for
traditional medical devices. This means that mHealth labeling, like traditional medical
device labeling, is tightly regulated. Unfortunately, these regulations are not contained in
one place. Common labeling regulations can be found in 21 C.F.R. Parts 801, 809, 812, 820,
830, and 1010. FDA Guidance Documents also explain labeling requirements [46, 58, 54].
Because labeling requirements are often uniquely tailored for each medical device, this section
only clarifies a few general requirements applicable to all medical devices.
mHealth application manufacturers must first understand that a device’s label and its labeling are different legal constructs. A label is more narrowly applicable, and it is defined in the
FD&C Act as “a display of written, printed, or graphic matter upon the immediate container
of any article” (21 U.S.C. § 321(k)). Labeling is defined in the FD&C Act as “all labels and
other written, printed, or graphic matter (1) upon any article or any of its containers or
wrappers, or (2) accompanying such article” (21 U.S.C. § 321(m)). Historically, labeling
has been interpreted broadly to encompass material like advertising, posters, pamphlets,
instructions for use, user manuals, quick-start guides, and packaging [2, 5, 46, 54].
Manufacturers should note that labeling must address both the intended use of the product
and its current use. For example, if the manufacturer knows that their device is to be
used for purposes other than its original purpose, the manufacturer must update its labeling
(including its directions for use) to accommodate these other use cases. [66, 3].
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As pursuant to the FD&C Act, labeling must not be misbranded (21 U.S.C. § 352) or contain
any false or misleading statements [46]. Labeling, including advertisements, are considered
misbranded if it is false or misleading to the user. This obviously includes both willful and
accidental deception from the manufacturer, but also includes truths that may “lead to a
false impression in the mind”, as “labeling can be deemed by the FDA to be in violation of
the law if it proves deceptive to the customer” [46]. Labeling characteristics common in tech
and other industries like “expressions of opinion or subjective statements” and “failure to
reveal material facts, consequences that may result from use, or the existence of difference
of opinion”, are categorized as misleading in the medical context [46].

4.1.5

Apps Must Be HIPAA Compliant If Used By Covered Entities

In short, the Health Insurance Portability and Accountability Act (HIPAA) is a piece of
legislation that governs how “covered entities” (e.g., health care providers like hospitals
and other organizations that bill patients, health plans like insurance providers, and health
care clearinghouses like billing services) and their “business associates” (an organization,
person, or subcontractor that creates, receives, maintains, or transmits “protected health
information”) handle “protected health information” (individually identifiable health information). Legal definitions of “covered entities”, “business associates” and “protected health
information” can be found at 45 C.F.R. § 160.103. The HITECH Act was passed in 2009
to encourage the adoption of electronic medical health records and to strengthen parts of
HIPAA. These two Acts were eventually merged into the 2013 HIPAA Omnibus Rule, and
today HIPAA usually refers to the merged regulation.
Note that HIPAA only applies to “covered entities” and their “business associates”. Therefore, an mHealth app that is not directly used by a healthcare provider, health plan, or
healthcare clearinghouse is exempt from HIPAA. For example, an mHealth app that monitors a user’s sleep that is not intended for use by “protected entities” may collect protected
health information not covered by HIPAA. However, if a hospital instructs a patient to download the same app, then the protected health information collected by the app is protected
by HIPAA. A good rule of thumb is that a manufacturer should make their mHealth app
HIPAA compliant if the manufacturer wants “protected entities” to be able to use their app.
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mHealth developers can think of HIPAA as consisting of three main Rules, the Privacy Rule
(45 C.F.R. Part 160 and Subparts A and E of Part 164), the Security Rule (45 C.F.R. Part
160 and Subparts A and C of Part 164), and the Breach Notification Rule (45 C.F.R. Part
164 Sections 400-414). The Privacy Rule is generally concerned with when protected health
information (PHI) can be transferred to another entity. The Security Rule is generally concerned with the security requirements needed to protect PHI. And the Breach Notification
Rule covers notification requirements when there is a suspected breach of PHI. Developers
might also be interested in the Enforcement Rule (45 C.F.R. Part 160 in Subparts C, D, and
E), which details how the U.S. Department of Health and Human Services’ Office of Civil
Rights (OCR) enforces HIPAA, including legal procedure and monetary penalties for noncompliance. The Department of Health and Human Services has extensive online resources
for HIPAA on its website [121].

4.1.6

New Frameworks on The Horizon

The FDA, working with other national health regulators, has defined Software as a Medical
Device (SaMD) as “software intended to be used for one or more medical purposes that
perform these purposes without being part of a hardware medical device”. SaMD includes
mHealth applications, also called Mobile Medical Applications (MMAs) [87].
The FDA is working on developing regulations for AI/ML-based SaMDs. Although currently lacking clear Guidance Documents, the FDA has released an action plan that details
what kind of regulations they will likely pursue in the future. These regulations include a
“tailored regulatory framework for AI/ML-based SaMD”, a “good machine learning practice (GMLP)”, a “patient-centered approach incorporating transparency to users”, “regulatory science methods related to algorithm bias & robustness”, and “real-world performance
(RWP) monitoring” [74]. The FDA regularly publishes discussion papers and requests for
feedback when developing guidelines, and this practice is expected to continue for AI/MLbased SaMDs [68].
The COVID-19 crisis also affects the regulation of mHealth applications. The FDA temporarily relaxed some mobile health regulations for the length of the COVID-19 emergency
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[72, 71]. Although these changes are temporary, they may become permanent when the public health emergency has been lifted. Mobile medical applications is an especially innovative
field, and those working in this area are encouraged to keep up with the latest publications
from the FDA.
Finally, developers may be interested in the FDA’s Breakthrough Devices Program or Digital
Health Software Precertification (Pre-Cert) Program, new programs that may help expedite
the approval of novel treatments and technologies [59, 70].

4.1.7

Where to Learn More

The FDA has many useful online materials for those who wish to learn about how devices are
regulated. Most questions have been answered somewhere on their website. The FDA has
many useful, detailed webpages, like their “Overview of Device Regulation” and “Classify
Your Medical Device” pages [73, 69]. The FDA’s Center for Devices and Radiological Health
(CDRH) is responsible for regulating medical devices. CDRH Learn is their online video
platform that explains their current policies.
FDA Guidance Documents explain official FDA policies, and all 2,500+ guidance documents
are searchable online [76]. Withdrawn medical device guidance documents are also searchable
online [77]. Unfortunately, it can be hard to determine when a guidance document has not
been withdrawn but instead has been replaced or merged into a newer document.
Those with further questions may contact the FDA’s Division of Industry and Consumer
Education (DICE) [62]. Each guidance document also contains contact information for questions pertinent to its subject area. Additionally, other organizations may provide consultants
with specialized expertise. Finally, developers should contact a lawyer, as each development
situation is unique.
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4.2

It Would Be Very Challenging to Automatically
Check if mHealth Applications Satisfy Security and
Privacy Regulations

After grappling with the current state of mHealth regulations, I conclude that it would be
very challenging to automatically detect if mHealth apps satisfy their FDA security and
privacy regulations. This is due to a few main reasons: (1) the open-ended design of the law
makes it difficult to operationalize, (2) the FDA’s reliance on “self-certification” of security
and privacy compliance, and (3) a complicated regulatory environment that makes it difficult
to know what regulations apply.

4.2.1

Current Regulations are too Open-Ended to be Meaningfully Operationalized

If an auditor wants to check if an mHealth application technically satisfies its security and privacy regulations, then the auditor needs specific, technical requirements to check. However,
existing regulations are often too open-ended to be used for auditing security and privacy
compliance. From a philosophical perspective, the law may be open-ended by design; by
avoiding specificity the law remains relevant, even as technology evolves.
Furthermore, because mHealth applications were grandfathered into the existing device regulatory environment, these existing regulations are often focused on securing the safety of
manufactured hardware devices. The creation of mHealth applications, sometimes called the
“manufacturing of software devices”, doesn’t quite fit into the existing regulatory framework.
Because of this misfit, there may be many ways to interpret how existing regulations apply
to mHealth applications.
For example, the Quality System Regulations, located at 21 C.F.R. Section 820, is commonly cited as an important federal regulation that ensures the safety of medical devices.
These regulations are also commonly cited when discussing the cybersecurity requirements
of healthcare devices, as cybersecurity risks can directly affect the safety of a medical device.
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However, the current Quality System Regulations are too open-ended to ensure strong cyber
safety. While these regulations may be satisfactory for experienced developers, inexperienced
developers may interpret these regulations in an unsafe way. Some sections of the Quality
System Regulations most relevant to cybersecurity read:

Design validation. Each manufacturer shall establish and maintain procedures
for validating the device design. Design validation shall be performed under defined operating conditions on initial production units, lots, or batches, or their
equivalents. Design validation shall ensure that devices conform to defined user
needs and intended uses and shall include testing of production units under actual
or simulated use conditions. Design validation shall include software validation
and risk analysis, where appropriate. The results of the design validation, including identification of the design, method(s), the date, and the individual(s)
performing the validation, shall be documented in the DHF. – 21 C.F.R. 820.30(g)
Quality audit. Each manufacturer shall establish procedures for quality audits
and conduct such audits to assure that the quality system is in compliance with
the established quality system requirements and to determine the effectiveness of
the quality system. Quality audits shall be conducted by individuals who do not
have direct responsibility for the matters being audited. Corrective action(s),
including a reaudit of deficient matters, shall be taken when necessary. A report
of the results of each quality audit, and reaudit(s) where taken, shall be made
and such reports shall be reviewed by management having responsibility for the
matters audited. The dates and results of quality audits and reaudits shall be
documented. – 21 C.F.R. 820.22

As the reader can see, these sections are so open-ended that firms may choose to satisfy these
regulations in a myriad of unsafe ways. “Design validation shall include software validation
and risk analysis, where appropriate” does not specify how rigorous “software validation” or
“risk analysis” must be, nor does the regulation specify what cyber risks firms need to look
for to be in compliance.
Similarly, while the Quality Audit provision requires that firms perform quality audits from
time to time, this section raises more questions than it answers. How often must audits be
performed? What should the audit consist of? Should firms hire a red team to look for
cyber vulnerabilities, or simply check that users are using new passwords each year? What
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are these “established quality system requirements” the regulation references? What does
it mean to “be in compliance” with “established quality system requirements”? And how is
the “effectiveness” of the quality system to be determined? Without specificity, it’s possible
to have firms satisfy these requirements without actually improving their cyber defenses.
Another reason why mHealth security and privacy regulations may be open-ended is that
open-ended requirements gives OEMs (original equipment manufactures) greater freedom to
design a cybersecurity strategy that is tailored to the individual needs of their application.
Because applications have different operating requirements, their security needs will also be
different. Detailed regulation that applies to all applications may ignore these differences,
which may actually weaken application cybersecurity. By leaving cybersecurity requirements
open-ended, the FDA allows experienced teams to develop cybersecurity strategies that are
tailored to application requirements.
Not all FDA mHealth security and privacy documentation is open-ended, though. In my
investigation, I found one document with very specific, operationalizable cybersecurity recommendations, a 2018 FDA draft guidance document titled “Content of Premarket Submissions for Management of Cybersecurity in Medical Devices” [60]. The recommendations in
this document, an FDA guidance document, are not legally binding. Also note this document is a “draft guidance”, which means that it’s not an official guidance document. Draft
guidance documents are often issued by the FDA to solicit feedback; they show us what the
FDA is currently thinking about. The content in this 20-page draft guidance may someday
replace the current 2014, 7-page “Content of Premarket Submissions for Management of
Cybersecurity in Medical Devices” guidance document [51].
This 2018 draft guidance splits devices into two categories. Tier 1 “Higher Cybersecurity
Risk” Devices, networked medical devices in which a cybersecurity incident could directly
lead to patient harm in multiple patients; and Tier 2 “Standard Cybersecurity Risk” Devices, which includes all devices not in Tier 1. From an implementation standpoint, this
guidance document has 22 specific recommendations to “identify and protect devices assets
and functionality”, and 15 specific design expectations to “detect, respond, [and] recover”
from a cybersecurity incident.
Security researchers will recognize that these recommendations are helpful. Some recommendations include:
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• “Employ a layered authorization model by differentiating privileges based on the user
role (e.g., caregiver, patient, health care provider, system administrator) or device
functions”.
• “Authenticate firmware and software. Verify authentication tags (e.g., signatures, message authentication codes (MACs)) of software/firmware content, version numbers, and
other metadata. The version numbers intended to be installed should themselves be
signed/have MACs. Devices should be electronically identifiable (e.g., model number,
serial number) to authorized users”.
• “Ensure capability of secure data transfer to and from the device, and when appropriate, use methods for encryption and authentication of the end points with which data
is being transferred”.
• “Use current NIST recommended standards for cryptography (e.g., FIPS 140-2, NIST26
Suite B27 ), or equivalent-strength cryptographic protection for communications channels”.
• “Implement design features that allow for security compromises to be detected, recognized, logged, timed, and acted upon during normal use”.
• “Ensure the design enables forensic evidence capture. The design should include mechanisms to create and store log files for security events. . . . Examples of security events
include but are not limited to configuration changes, network anomalies, login attempts, and anomalous traffic (e.g., sending requests to unknown entities)”.
• “Implement device features that protect critical functionality and data, even when the
device’s cybersecurity has been compromised”.

Notice that these recommendations are more specific than the Quality System Regulations,
yet remain intentionally open-ended so teams can choose to satisfy these recommendations
based on their application’s operational requirements. For example, “layered authorization”
is generally a good idea. So are “device features that protect critical functionality and
data”. How these recommendations should be met, however, is not specified – the FDA
leaves implementation details up to the developers.
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Thus, these more-specific recommendations, like the more open-ended Quality System Regulations, leave applications vulnerable to poor implementation errors. However, it’s critical
to note the difference between the recommendations in the 2018 draft guidance and the
Quality System Regulations: the Quality System Regulations is so open-ended that it is
hard to operationalize. On the other hard, the recommendations in the 2018 draft guidance
document are much more well-defined.
This specificity makes a world of difference. Previous research suggests that as long as security requirements are well-defined, we may be able to audit poor security implementations
(e.g., see CryptoGuard [1]). Although these auditors will never be 100% accurate, they
may be able to catch a significant number of security-related implementation errors while
an application is still in development.
The 2018 draft guidance document “Content of Premarket Submissions for Management
of Cybersecurity in Medical Devices” is enormously helpful. However, most cybersecurity
regulations and recommendations are more similar in substance to the Quality System Regulations. Finally, I add that while the draft guidance was released on October 18, 2018, its
150-day comment period closed on March 17, 2019. This draft guidance has not yet been
replaced by a new, official guidance document.

4.2.2

Current Regulations Rely on “Self-Certification”

Currently, the FDA primarily relies on firms to “self-certify” that their software devices are
“secure enough”. This collaborative system of “self-certification” makes it more difficult for
the FDA to determine when an application fails to meet its security and privacy requirements.
This is because a system of “self-certification” relies on trust; the FDA must trust that firms’
self-evaluations are correct. However, given the large number of mHealth applications, it is
inevitable that the FDA will end up trusting some inexperienced developers or bad actors
that produce an unsatisfactory products. There’s no way for the FDA to be completely sure
of the security and privacy of every mHealth application without testing them all.
The FDA splits cybersecurity concerns into two general categories: (1) controlled risks, and
(2) uncontrolled risks. Each firm must try to turn all “uncontrolled risks” into “controlled
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risks”, explain how they did so, and argue that any remaining risks, controlled or not, are
acceptable.
The determination of what counts as a “controlled risk” or an “uncontrolled risk” depends
on the risk’s exploitability and the severity of patient harm if exploited. To evaluate exploitability, the FDA suggests some tools like the “Common Vulnerability Scoring System
Version 3.0”, the “AAMI TIR57: Principles for Medical Device Security – Risk Management
Framework”, and the “IEC 80001: Application of Risk Management for IT Networks Incorporating Medical Devices Framework”, though firms may use whatever system they please
(including their own). The FDA’s definitions for the severity of patient harm are more focused. Severity ranges include negligible (inconvenience or temporary discomfort), minor
(results in temporary injury or impairment not requiring professional medical intervention),
serious (results in injury or impairment requiring professional medical intervention), critical
(results in permanent impairment or life-threatening injury), and catastrophic (results in
patient death). A diagram helps explain these relationships [56].

Figure 4.1: Controlled vs. Uncontrolled Cybersecurity Risks in mHealth.
Image from Postmarket Management of Cybersecurity in Medical Devices (2016) [56]
If a particular medical application requires premarket or postmarket submissions, firms must
identify all cybersecurity risks and tell the FDA why these risks are all “controlled risks”.
This system, however, relies on firms’ “self-evaluation”. The FDA may claim that a firm’s
actions to remediate cybersecurity risks is inadequate, but for the most part, it appears that
the FDA must trust that a firm’s self-evaluation and implementation was done correctly.
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I suspect this system of “self-evaluation” is in-place because it can be difficult for a thirdparty, even a third-party with governmental authority, to effectively assess a firm’s cybersecurity risk. This is especially acute because many of the recommendations the FDA gives
are difficult for a third-party to assess.
For example, the FDA writes “manufactures may wish to deploy an additional control(s) as
a part of a ‘defense-in-depth’ strategy” to manage “controlled risks” [56]. Defense-in-depth
strategies, and their correct implementation, are left up to each firm. There are benefits to
this approach, as it gives firms the flexibility to design a “defense-in-depth” strategy that
is tailored to the needs of their application. This flexibility, though, makes it difficult for
the FDA to audit the strength of all “defense-in-depth” strategies. There are many firms
creating mHealth applications and each firm will have their own “defense-in-depth” strategy.
It is unreasonable to expect the FDA to have the expertise or resources to evaluate each of
these firm’s strategies.
Let’s look at another example. For newly discovered “uncontrolled risks”, the FDA recommends that “[if] fixing the vulnerability may not be feasible or immediately practicable,
manufactures should identify and implement risk mitigations and compensating controls to
adequately mitigate the risk” and recommends that “customers and the user community
should be provided with relevant information on recommended controls and residual cybersecurity risks so that they can take appropriate steps to mitigate the risk and make informed
decisions regarding device use” [56]. Some vulnerabilities may need to be reported to the
FDA, though other vulnerabilities (even critical vulnerabilities) may not need to be reported
[56]. Again, because the FDA gives firms great flexibility in how they choose to satisfy their
cybersecurity requirements, the FDA may not be well placed to determine if fixing a new vulnerability is “feasible or immediately practicable” – firms may be better positioned to make
this judgement. While this framework allows the people with the best understanding of an
application (i.e., the firms) to determine the severity of a cybersecurity risk, it also requires
that regulatory bodies trust these firms’ self-evaluation of their products. This trust may be
well-placed for experienced teams; however, inexperienced teams may unintentionally make
mistakes in their cybersecurity implementations.
The practice of relying on a system of “self-certification” is not new for government agencies.
In fact, this system is pretty common, even in highly regulated industries like the defense
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industry. One can argue that it may not be appropriate or efficient for the FDA to check
implementation details, like if all health firms’ cloud configurations are “secure-enough”.
One can also argue that more prescriptive guidelines would stifle innovation and lead to less
secure, suboptimal outcomes. Another argument can be made that open-ended requirements
give expert teams the flexibility they need to design cybersecurity controls that suit an
application’s operational requirements. I’m not disagreeing with any of these arguments.
Instead, I claim that open-ended regulations and a system of “self-certification” comes with
inherent trade-offs. While allowing experienced teams to design their own cybersecurity
solutions may be helpful, this same system gives inexperienced teams or bad actors the
leeway to design inadequate solutions.
Finally, I note that there are also alternatives to this trust-based regulatory framework. For
example, the California Air Resources Board adopts an antagonistic approach to vehicle
emission regulatory compliance. Instead of a trust-based system of “self-certification”, all
vehicles sold in California must be tested at a facility to verify that their emissions satisfy
California regulations. One can argue that this antagonistic approach may be more effective
than a trust-based approach in ensuring that all vehicles meet their emission requirements.
However, this antagonistic approach may require more resources (e.g., for the development
of complicated testing procedures [22], then to fund these extensive tests). And finally, this
antagonistic approach requires a set of criteria that is testable. Currently, the open-ended
nature of mHealth security and privacy regulations makes these regulations difficult to test
at scale.

4.2.3

It’s Unclear What Regulations Apply

Finally, it’s important to note that the current regulatory environment is very complicated.
So complicated, in fact, that it can be hard to determine what regulations and what FDA
guidance documents even apply to a product. Without knowing what regulations or recommendations to check for, we cannot automate a process to check for legal compliance.
mHealth application developers are subject to federal regulations in the U.S.C and the
C.F.R., in addition to federal case law. Title 21 of the C.F.R. alone (the part of the C.F.R.
devoted to rules for the FDA) was a whopping 4,907 pages in 2020 [127, 128, 129, 129, 130,
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131, 132, 133, 134, 135]. Furthermore, mHealth app developers are also subject to state laws
and state case law.
In addition to the vast quantity of regulations mHealth application developers must satisfy,
the FDA’s guidance documents present an additional challenge. While these guidance documents usually do not represent legal requirements, they are often important because they
explain how the FDA will exercise its legal authority. When the law is ambiguous or leaves
enforcement details up to the FDA, these guidance documents explain the FDA’s position.
However, understanding these FDA guidance documents is itself a challenge. There are over
2,500 guidance documents currently active; each of these documents are searchable online
[76]. Thankfully, all of the 200+ withdrawn guidance documents are also searchable via an
FDA database [77]. However, it can be difficult to determine when a guidance document
has been updated. One must manually investigate (e.g., through Google) to determine if
a guidance document has been replaced with a newer version of the same name, and it’s
especially difficult to determine if a guidance document has been updated or merged into a
newer document with a different name.
It is also difficult to determine what the FDA’s policies are when multiple guidance documents apply to same application. Which guidance should the developer follow? As an
example of the complexity of this environment, I’ve compiled a table that features a few of
the most important regulations and FDA guidance documents, organized by category. Note
how these documents often overlap.
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Medical Devices;
Reports of Corrections and
Removals (21
CFR 806)

Medical Device
Reporting (21
CFR Part 803)

Investigational
Device Exemption (IDE) (21
CFR Part 812)

Premarket Notification 510(k)
(21 CFR Part
807 Subpart E)

Premarket Approval of Medical Device (21
C.F.R. 814)

Medical Device
Listing (21 CFR
Part 807)

Establishment
Registation (21
CFR Part 807)

Labeling (21
C.F.R. 801)

HIPAA (Health
Insurance Portability and Accountability
Act)

QS Regulations
(21 C.F.R. 820)

Food and Drugs
(Title 21 of
C.F.R.)

Policy for Device
Software Functions
and Mobile Medical
Applications

Food, Drug, and
Cosmetic Act
(FD&C Act) [21
U.S.C. Chapter
9]

Developing the Software Precertification
Program: Summary of
Learnings and Ongoing
Activities

Artificial Intelligence/Machine Learning (AI/ML)-Based
Software as a Medical
Device (SaMD) Action
Plan

General Principles of
Software Validation

Multiple Function Device Products: Policy
and Considerations

General Wellness:
Policy for Low Risk
Devices

Changes to Existing
Medical Software Policies Resulting from
Section 3060 of the
21st Century Cures
Act

Clinical Decision Support Software

Medical Device Data
Systems, Medical Image Storage Devices,
and Medical Image
Communications Devices

Off-The-Shelf Software
Use in Medical Devices

Guidance for the Content of Premarket
Submissions for Software Contained in
Medical Devices

Software

Legal

Multiple
Function
Device
Products:
Policy and
Considerations

Postmarket
Management
of Cybersecurity in
Medical Devices Radio
Frequency
Wireless
Technology
in Medical
Devices

Cybersecurity
for Networked
Medical
Devices
Containing
Off-theShelf (OTS)
Software

Content of
Premarket
Submissions
for Management
of Cybersecurity
in Medical
Devices
(2014)

Cybersecurity
Content of
Premarket
Submissions
for Management
of Cybersecurity
in Medical
Devices
(2018)

Radio
Frequency
Wireless
Technology in
Medical
Devices

Medical
Device
Data Systems,
Medical
Image
Storage
Devices,
and Medical Image
Communications
Devices

Design
Considerations and
Premarket
Submission
Recommendations for
Interoperable
Medical
Devices

Cybersecurity
for Networked
Medical
Devices
Containing
Off-theShelf
(OTS)
Software

Networks

Multiple
Function
Device Products: Policy
and Considerations

General
Electronic
Products Identification
(21 CFR §
1010.3)

Deciding When to
Submit a 510(k) for
a Change to an Existing
Device

QS Regulations Labeling and
Package Control (21 CFR
820 Subpart
K)

General Principles of
Software Validation

Applying Human Factors and Usability Engineering to Medical
Devices

Requests for Feedback
and Meetings for Medical Device Submissions:
The Q-Submission Program

FDA and Industry Procedures for Section
513(g) Requests for
Information under the
Federal Food, Drug, and
Cosmetic Act

Modifications to Devices
Subject to Premarket Approval (PMA) The PMA Supplement
Decision-Making Process

Humanitarian Device
Exemption (HDE) Program

De Novo Classification
Process (Evaluation of
Automatic Class III
Designation)

Developing the Software Precertification
Program: Summary of
Learnings and Ongoing
Activities

Breakthrough Devices
Program

HIPAA (Health Insurance Portability and
Accountability Act)

QS Regulations (21
C.F.R. Part 820)

Organizational

Labeling
of Investigational
Devices (21
CFR § 812.5)

Unique
Device Identification (21
CFR 830)

In Vitro
Diagnostic
Products for
Human Use
- Labeling
(21 CFR 809
Subpart B)

Labeling (21
CFR 801)

Labeling Regulatory
Requirements for
Medical Devices (FDA
89-4203)

Labeling

FDA and Industry
Procedures for Section
513(g) Requests for
Information under the
Federal Food, Drug,
and Cosmetic Act

De Novo Classification
Process (Evaluation
of Automatic Class III
Designation)

Developing the Software Precertification
Program: Summary of
Learnings and Ongoing
Activities

Appropriate Use of
Voluntary Consensus
Standards in Premarket Submissions for
Medical Devices

Design Considerations
and Premarket Submission Recommendations
for Interoperable Medical Devices

Content of Premarket Submissions for
Management of Cybersecurity in Medical
Devices (2014)

Content of Premarket Submissions for
Management of Cybersecurity in Medical
Devices (2018)

Guidance for the Content of Premarket Submissions for Software
Contained in Medical
Devices

Premarket Notification
510(k) (21 CFR Part
807 Subpart E)

Premarket Submissions
Premarket Approval
of Medical Device (21
C.F.R. 814)

Table 4.1: A Partial Listing of Important FDA Guidance Documents, by Subject

Developing the
Software Precertification Program:
Summary of
Learnings and
Ongoing Activities

Modifications to
Devices Subject
to Premarket Approval (PMA) The PMA Supplement DecisionMaking Process

Deciding When to
Submit a 510(k)
for a Change to an
Existing Device

Distinguishing
Medical Device
Recalls from
Medical Device
Enhancements

Postmarket
Surveillance
Under Section
522 of the Federal
Food, Drug, and
Cosmetic Act

Medical Device
Reporting for
Manufacturers

QS Regulations
(21 C.F.R. 820)

Medical Devices;
Reports of Corrections and
Removals (21 CFR
806)

Medical Device
Reporting (21
CFR Part 803)

Postmarket Management of Cybersecurity in
Medical Devices

Reporting

Another challenge is that the health regulatory environment is very convoluted. While
scholars are unsure about how to study legal complexity, one proposed method is to measure
how many other documents each legal unit cites [26, 25]. I utilize this method to study the
out-bound citation network for key mHealth FDA guidance documents.
These citation networks are critical. FDA guidance documents, laws, and other policies do
not exist in a vacuum. Oftentimes, these documents rely upon principles and regulations
from other documents. Therefore, to understand a document, one may need to be familiar
with its citations. However, my investigation suggests that the complexity of FDA guidance
documents and the many other documents they cite may weaken the explanatory purpose
of these guidance documents.
As a part of my investigation, I created a graphic that maps the out-bound citations for
eleven key FDA mHealth guidance documents. These eleven original documents ultimately
reference 133 other documents a total of 239 times. On average, each of the original FDA
guidance documents cites 21.72 other documents.
The eleven original FDA guidance documents are: “Policy for Device Software Functions
and Mobile Medical Applications”, “Content of Premarket Submissions for Management of
Cybersecurity in Medical Devices (2018)”, “Content of Premarket Submissions for Management of Cybersecurity in Medical Devices (2014)”, “Guidance for the Content of Premarket
Submissions for Software Contained in Medical Devices”, “Off-The-Shelf Software Use in
Medical Devices”, “Cybersecurity for Networked Medical Devices Containing Off-the-Shelf
(OTS) Software”, “Postmarket Management of Cybersecurity in Medical Devices”, “General
Principles of Software Validation”, “Medical Device Reporting for Manufacturers”, “Distinguishing Medical Device Recalls from Medical Device Enhancements”, and “Design Considerations and Premarket Submission Recommendations for Interoperable Medical Devices”
[66, 60, 51, 49, 65, 48, 56, 47, 55, 52, 58].
This graphic shows the distributed and convoluted nature of the regulatory landscape. To
understand these eleven FDA Guidance Documents, one may need to be familiar with over
200 other documents. All of these other documents (especially the legal documents and other
FDA Guidance Documents) have their own dependencies. The complexity of this citation
network grows exponentially.
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Figure 4.2: Out-Bound Citations for Eleven FDA Guidance Documents

4.3

The Use of Non-legal, Authoritative Guidance Documents That Explain Regulatory Intent May Aid
in the Creation of Automated Auditors

The previous sections describe some key challenges that make it difficult to computationally
audit mHealth security and privacy regulatory compliance: the open-ended nature of the law,
the FDA’s reliance upon “self-certification”, and the complicated regulatory environment.
In previous sections, I speculate why our regulatory environment was designed this way and
explain some of the pros and cons of our current approach.
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While our current regulatory approach has many benefits, I do note that its current design
makes it hard to audit application compliance. The open-ended nature of the law is an
especially large challenge, as auditors (especially computational auditors that can scale to
millions of apps) require specific, technical specifications to check against. If a regulation
can be satisfied in thousands of different ways, there is no good way for a computational
auditor to check every possible compliance strategy. There are simply too many. An auditor
that tries to cover many regulations, each of which have thousands of compliance strategies,
may be too difficult to create. Furthermore, even if we could create such an auditor, it may
suffer from too many false-positives or false-negatives.
Because of these challenges, I wonder if it would be better to create the auditor in another
way – can we use non-legal, authoritative guidance documents that explain regulatory intent
to create an auditor? This solution may not be intuitive; the conventional wisdom is to
operationalize the law itself if we are trying to create an auditor that checks for compliance
with the law. It seems counter-intuitive to willingly set aside the law and instead rely upon
non-legal documents.
But, the use of non-legal documents brings important benefits. Because these documents
do not carry the full weight of the law, authoritative bodies (e.g., the FDA, NIST) can give
more-specific recommendations while preserving the open-ended nature of the law. Furthermore, because these recommendations are not mandatory, they can be specific-enough to
aid inexperienced developers, yet not prescriptive, giving experienced developers the freedom to design their own security solutions. And, a comprehensive guidance document can
also help clarify the current regulatory framework. If this document distills many convoluted
rules into list of actionable insights, developers may not feel the need to parse through other
regulations and their dependency networks.
It’s also important to note that these documents must be authoritative. Not all interpretations of regulatory intent may satisfy the government. The good news, however, is that many
authoritative bodies may have the legal sophistication to create these guidance documents.
These documents can come from the government itself (e.g., the FDA), but can also come
from other authoritative bodies (like industry groups, research organizations, or non-profits).
Technologists do not need to wait for the government to make an “official” document that
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clarifies regulatory intent. This operationalization can come from many places, as long as
their legal interpretation is trustworthy.
Related work in the Security and Privacy Laboratory at Washington University in St. Louis
suggests that the use of these non-legal, authoritative guidance documents that clarify regulatory intent is a promising way to create automated, computational auditors. This work uses
the 2018 FDA draft guidance document “Content of Premarket Submissions for Management
of Cybersecurity in Medical Devices” as the non-legal, authoritative guidance document that
is operationalized into an auditor [60]. The recommendations in this draft guidance document are specific-enough such that we were able to create an auditor that uses static analysis
techniques to detect potential violations of FDA security and privacy recommendations.
While this auditor did not include all FDA security and privacy recommendations for
mHealth applications, the auditor’s creation does show the potential of using non-legal,
authoritative guidance documents as the basis of computational auditors. Guidance documents, because they are non-legal, can be written to arbitrary degrees of specificity. As long
as these guidance documents are specific-enough to computationally operationalize, we can
use them to create an auditor that checks if applications satisfy their legal requirements, all
while preserving the open-ended nature of the law.
However, it’s important to note that by using non-legal, authoritative guidance documents
that clarify regulatory intent to create auditors, we are not teaching computers to understand and reason about the law. The hard problem of legal interpretation (going from law to
operationalizable items) must still be done by experts. This proposal suggests that human
interpretations can be operationalized for computers, which can potentially enable the creation of automated auditors. Getting computers to reason about the law remains an open
question.
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Chapter 5
Related Work
We can organize other work that combines computer science and legal analysis into a few
categories.

5.1

Artificial Intelligence, Machine Learning, and Natural Language Processing

Many projects that intersect legal academia and the computer science security and privacy community have focused on the analysis of privacy policies. Many projects, like the
Usable Privacy Project, seek to use natural language processing and crowdsourcing to semiautonomously extract key provisions from privacy policies and organize them in a userfriendly way [142, 141].
Bhatia et al. (2016) use Tregex, a tree regular expression language, to identify hyponyms (i.e.,
specific examples) present in privacy policies. They found that the vocabulary used in privacy
policies is very different than the vocabulary used in popular lexical databases [21]. Kumar et
al. (2020) use supervised machine learning to automatically extract opt-out hyperlinks from
privacy policies [18]. Zimmeck et al. (2019) use supervised machine learning and natural
language processing to automatically extract privacy practice descriptions from Android
apps. Static analysis of apps’ Android APIs, strings, class structures, and permissions checks
if data (e.g., location data accessed through an API) is used without being disclosed in a
privacy policy [171].
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Other research outside of the computer science security and privacy community focuses on
legal information retrieval and prediction [80, 170, 20]. One example of legal information
retrieval involves search engines – given a legal query, can a search engine find relevant
legal documents (e.g., judicial decisions, legal statutes). Participants in the Competition
on Legal Information Extraction/Entailment (COLIEE) have used a variety of techniques
to improve legal information retrieval. Kim and Goebel (2017) use TF-IDF and language
model-based information retrieval [101]. Tran, Nguyen, and Satoh (2019) apply encoded
summarization and lexical matching [156]. Shao et al. (2020) use word-entity duet representations [147]. And Gain et al. (2021) use BM25 and Bidirectional Encoder Representations
from Transformers (BERT) [81]. Information retrieval in the legal domain is different than
general information retrieval; the many differences between legal and general language may
complicate the application of traditional NLP techniques to the legal domain [168, 170, 108].
Another area of research is using computation to predict the outcome of judicial decisions.
Legal judgement prediction has long been of interest of the legal community [102, 116]. Recently, researchers have applied AI and NLP to improve predictive results. Katz, Bommarito,
and Blackman (2017) use random forests to predict US Supreme Court voting behavior with
70% accuracy [99]. Aletras et al. (2016) use a support vector machine to predict judicial
decisions from the European Court of Human Rights with 80% accuracy [9]. Wang and
Jin (2020) combine convolutional neural networks and recurrent neural networks to predict
judicial decisions from the Supreme People’s Court of China [163].

5.2

Logical Frameworks, Privacy Languages, and Legal
Ontologies

One branch of research tries to take legal documents and precisely represent them with
knowledge representation languages. Some researchers attempt to represent privacy policies
in logical frameworks. Breaux and Rao (2013) use Description Logic to model actors, data,
and data use purpose hierarchies in Facebook, Zynga, and AOL-Advertising privacy policies.
Their investigation is motivated by the fact that digital products (e.g., Zynga’s Farmville
game) often depend on many technological actors (e.g., Farmville was playable on Facebook,
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where ads were then served by AOL). However, the privacy policies of Zynga, Facebook, and
AOL-Advertising may contain contradictory requirements. [30].
Instead of presenting privacy policies as knowledge representation languages, other researchers
have developed new languages to enforce privacy and security requirements (e.g., access control frameworks). EPAL includes support for hierarchies, obligations, and conditions a firm
may specify in its privacy policy [16]. XACML is another attribute-based access control
system, though it lacks adequate support for the temporal conditions often found in privacy
regulations [19, 40]. Other privacy languages and proposals (like P3P and Do-Not-Track)
can be too domain-specific and therefore cannot effectively be applied to the legal system
[39, 124, 40]. Researchers affiliated with CodeX, the Stanford Center for Legal Informatics,
have found more success applying structured programming languages and formal logic to
contract law, as the domain-specific qualities of contract law are more amenable to computation [155, 83].
This domain-specific approach is not unique; researchers who study how to apply logical
programming to specific subsections of the law (instead of privacy policies) often focus on
very narrow applications. In the 1980s, Sergot et al. modeled the British Nationality Act of
1981 in the Prolog logic language; one of their conclusions was that the vagueness of the law
precluded its nuanced analysis [146]. More recently in 2005, Hilty, Basin, and Pretschner use
distributed temporal logic to model future access controls, an idea often found in security
and privacy regulation [92]. In 2010, DeYoung et al. use least fixed point logic to create a
logical framework called PrivacyLFP to formalize the transmission-related portions of the
Health Insurance Portability and Accountability Act (HIPAA) and the Gramm-Leach-Bliley
Act (GLBA). PrivacyLFP includes support for disclosure purposes, real-time constructs, and
self-reference via fixed points. The authors argue that their logical specification reveals that
the law cannot be completely mechanized; they find that a large portion (e.g., almost all
HIPAA clauses) are “inherently subjective”, and well-over-half of the clauses require human
involvement (often expert human involvement) at the time of data access or audit [40].
Perhaps because of this subjectivity, since the 1990s much research in applying logic to
the law has been focused on ontologies [20]. While ontologies have a historical meaning in
philosophy and other related fields, ontologies in logical legal research follows the AI definition – the explicit specification of a conceptualization (i.e., model) of the legal domain.
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This includes explicit definitions of the logic, structure, and relationships in our legal system
and its many sub-domains [159]. Ontologies are critical in AI, and provide a shared vocabulary and allow for the creation and development of domain-specific knowledge [159, 88].
Without these explicit definitions and shared vocabulary, it is challenging to “translate”
legal concepts and statues into a logical framework. I encountered this problem in my own
research; the open-ended nature of the law complicates its translation into a well-defined,
computer-friendly format.
The creation of legal ontologies remains an active, unsettled, and pressing research area.
However, research in creating legal ontologies is very difficult. From a measurement perspective, no one fully knows what the law looks like or how it is used. In fact, the U.S. Justice
Department once tried to count the number of federal criminal laws in the U.S. Code; they
were unsuccessful. Current estimates peg the number from 10,000 to 300,000 [79]. Others
have tried to understand the structure of the legal system by analyzing the hierarchical structure, citation network, associated text function, and between-word Shannon Entropy of legal
collections like the U.S. Code [26]. Others have measured when key words (e.g., “privacy”)
entered legal documents, page length, paragraph count, and word count [161, 112, 32, 107].
However, while these studies can help us better understand our legal structure and the effects
laws have in our society, these discoveries are also reminders about how little we currently
know about the legal system. For example, Liebman et al. (2017) reviewed tens of millions
of historical judicial judgements from China’s Henan province and in a random sample found
that roughly half of the administrative lawsuits in their corpus reflect an underlying civil
dispute. This directly defies conventional wisdom, as we expect civil disputes to be resolved
through civil lawsuits [108]. It’s hard to create a model and ontology of the legal system
when we’re currently unclear about how exactly the legal system is used and structured.
Perhaps an even greater challenge to creating legal ontologies is that there are currently many
philosophically unknown questions about the fundamental nature of the law. For example,
those who have been able to accurately predict judicial decisions have used this predictive
power to argue that the law in practice is more similar to legal realism (in which social
interests and public policy influence the outcome of a case) than legal formalism (in which
the rules of the law uniquely determine a judicial outcome) [9]. This question of how laws are
interpreted and applied remains an unanswered question in legal philosophy; it may never
be answered. I previously mentioned that there are other key, unanswered legal questions
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that are fundamental to our legal system (e.g., federalism). The philosophical and political
realities of the law prevent its simple classification. I, too, note this difficulty in my research
in mHealth: it’s hard to know what and how regulations apply when the relationship among
legal documents is convoluted and imprecise. Some modeling techniques, like mapping the
outbound citation network, may give structure to some relevant documents; however, the
relationship among these documents remain unclear.

5.3

Modeling Legal and Philosophical Ideas

Other work, instead of directly trying to understand the law, focuses on modeling legal and
philosophical ideas. The law is ultimately grounded in philosophy (e.g., our conceptions of
what is right and wrong, our definition of privacy, our beliefs about the role of the state in
private affairs) and the trade-offs inherent in the political decision-making process. Modeling
these larger philosophical ideas is like creating a philosophical superset; a subset of these
ideas comprises our current laws. Furthermore, once this subset of ideas has been identified,
we can try to formalize these ideas into a computation-friendly representation. This kind of
meta-analysis, therefore, is related to the creation of an ontology used to study computation
and the law.
One example of this kind of philosophical inquiry is Nissenbaum’s theory of Contextual
Integrity [117]. Contextual Integrity builds upon the rich, historical, social-scientific study
of the “spheres” – or the distinct roles, places, and fields that comprise our society [85,
27, 28, 162, 111]. Nissenbaum identifies two norms that categorize our expectations of
privacy (i.e., the “norms of appropriateness” and the “norms of flow or distribution”) and
argues that we feel that our privacy has been violated when one of these norms have been
transgressed. These norms are specific to each “field” we inhabit, and therefore depend on
the context of the transmission, information included in the transmission, the agents who
are sending and receiving the information, and other terms placed on the transmission. This
theory is descriptive and focuses on when people feel their privacy has been violated through
information transmission (n.b. its well-defined scope).
The development of such a theory allows for its formalization in a logical context. Barth et
al. (2006) formalize Contextual Integrity to focus on who the information is about, how the
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information is transmitted, and what past and future actions are allowed and disallowed by
both the subject and the receivers of the information. They then apply linear temporal logic
(LTL) to this more-concrete definition of Contextual Integrity to model some information
transmission restrictions present in the Health Insurance Portability and Accountability
Act (HIPAA), the Children’s Online Privacy Protection Act (COPPA), and the GrammLeach-Bliley Act (GLBA). Unlike privacy languages that represent transmission rules using
functions, their formalization of Contextual Integrity represents transmission rules as logical
formulas. Their representation of these transmission restrictions in a logical framework
instead of as functions means that their logical implementation is fundamentally different
than the approach taken by privacy languages; their research provides a summary of the
different capabilities and limitations of different privacy languages (RBAC, XACML, EPAL,
P3P) and their linear temporal logic formalization of Contextual Integrity [19]. However, this
formalization, while impressive, remains incomplete. For example, it is limited to information
transmission, does not cover group actors, and does not touch upon case law. Some of these
limitations are due to the inherent restrictions of the Contextual Integrity framework.
It’s important to mention that Contextual Integrity has been formalized in other ways as
well. Apthorpe, Varghese, and Feamster (2019) interpret Contextual Integrity as comprising
of five parameters: “(1) the subject of the information being transferred, (2) the sender of
this information, (3) the attribute or type of information, (4) the recipient of the information,
and (5) the transmission principle or condition imposed on the transfer of information from
the sender to the recipient”. They then surveyed 200 parents with children from ages 3-13
and examine if the privacy transmission restrictions in COPPA for IoT smart-toys aligned
with parental expectations. Importantly, to formalize COPPA’s transmission principles, they
used the Federal Trade Commission’s (FTC’s) Six Step Compliance Plan for COPPA [10].
The FTC’s formalization of COPPA is important, as it gives an authoritative summary of
COPPA, which by itself may be very complicated and poorly understood [37]. This FTC
explanation is similar to the FDA’s guidance documents – they are non-legal, authoritative
documents that complement formal law.
Others have sought to model legal and philosophical ideas in other ways. Garg, Goldwasser,
and Vasudevan (2020), in response to “right to be forgotten” laws, ask the question “what
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does it truly mean to delete data”. They model data collectors as Interactive Turing Machines, define what qualifies as an insert, lookup, and deletion, and theorize as to when a
data collector is statistically deletion-compliant [82].
Cohen and Nissim (2020) attempt to formalize the EU’s General Data Protection Regulation
(GDPR)’s concept of “singling out”. While protection from “singling out” is required by the
GDPR, what this legal requirement means is much less clear. Cohen and Nissim attempt
to capture the intent of this regulation mathematically by defining a privacy attack called
“predicate singling out”. A design that is secure against “predicate singling out” (PSO
secure) is a necessary (but perhaps not sufficient) condition to be compliant with the GDPR’s
protections from “singling out”. Finally, they show that k-anonymity is not PSO secure, but
differential privacy implies PSO security [36]. Because the GDPR’s definition of “singling
out” was insufficiently detailed, they had to model what they believed was the intention
behind this rule to represent this rule in a mathematical framework.
On the case law side, Sheffler and Varia (2021) explain the foregone conclusion doctrine,
a legal doctrine in the United States center to the unresolved question about the limits of
government-compelled decryption and disclosure. They create foregone conclusion games
to explicitly define their definition, then walk through a few cryptographic systems (e.g.,
one-way functions, symmetric encryption) and show in what situations the government can
and cannot compel the defendant to decrypt her data [143].
In all of these examples, researchers had to create new models of legal concepts. Sometimes
these models were supersets of legal rules (e.g., Contextual Integrity for information transmission), while other models were a smaller refinement of a larger concept (e.g., “predicate
singling out” is a necessary but not sufficient condition for “singling out”). In all of these
examples, the original legal idea was insufficient in some way for precise analysis (e.g., too
vague, unsettled philosophical question). In these situations, researchers need to extrapolate
what they believe to be the intent behind the law and model it in a computation-friendly
way.
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Chapter 6
Conclusion
In this thesis, I asked the two following questions: (1) can we teach computers to understand the law, and (2) can we automate checking for legal compliance? To investigate these
questions, I pursued a case-study in mHealth security and privacy regulations.
To show the benefits of applying computation to legal analysis, I argue that by automating the auditing of mHealth security and privacy regulations, we can ultimately encourage
equitable mHealth adoption and reduce inequalities in healthcare.
To make this argument, I introduced a theoretical model of technology adoption. In this
model, technology adoption is directly affected by one’s trust in the technology, technological momentum, market conditions, technological access, and other factors. One’s trust
in technology is ultimately built through two pathways, each of which require two necessary conditions. These two pathways are one’s trust in oneself (e.g., through first-hand
experiences) and through one’s network of trusted intermediaries (e.g., government entities,
authority figures, journalists, friends, social groups). The two necessary conditions for trust
are the technology’s theoretical effectiveness (i.e., the ability for an application or technology
to theoretically meet the demands of its users) and practical effectiveness (i.e., applications
must satisfy user demands in practice, not only in theory).
I then examined if it is possible to automate compliance checking given existing mHealth
security and privacy regulations. Because of the breadth of these regulations, I limit my
investigation in scope to federal rules and regulations and exclude case law. As a part of this
investigation, I give a comprehensive summary of the current federal mHealth regulatory
environment.
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I conclude that it is very challenging to automatically check if mHealth applications satisfy
current security and privacy regulations. This conclusion relies upon three observations.
The first observation is that current regulations are too open-ended to be meaningfully
operationalized, which prevents the translation of these regulations into a precise, machinereadable format. My second observation is that regulations currently rely too much on “selfcertification”, which makes objective measurements of an mHealth app’s security and privacy
difficult. The FDA does not ask for the detailed information required to verify satisfactory
implementations of security and privacy controls. My third observation is that it’s unclear
what federal regulations or recommendations even apply to one’s mHealth application. These
regulations and recommendations often overlap and rely on other documents, which quickly
snowballs into an unmanageable network of legal documents one must know and satisfy.
However, I note that the use of non-legal, authoritative guidance documents that explain
regulatory intent may help with the creation of computational auditors. Because these
documents do not carry the full weight of the law, they can be arbitrarily specific, all the
while allowing the law to remain open-ended. Furthermore, because these documents are
not mandatory, they can be specific-enough to help inexperienced developers, while not
being prescriptive, giving experienced developers the freedom to design their own security
solutions. And finally, if these documents distill many convoluted rules into actionable
insights, developers may not feel the need to parse through other regulations and their
dependency networks.
Related work in the realm of computational legal analysis generally focuses on: (1) utilizing
artificial intelligence, machine learning, and natural language processing to identify key statements, improve legal search, and predict the outcome of judicial decisions; (2) the creation
of logical frameworks, privacy languages, and legal ontologies to represent and communicate
legal ideas; and (3) modeling legal and philosophical ideas by extrapolating the intent or
philosophical basis behind laws, and translating this extrapolation into a computationallyfriendly representation.
The challenges present in conducting computational legal research suggests that future work
should focus on conducting basic research in legal computation. Because significant basic
questions about the structure and usage of the law remains a mystery, it is hard to model
the law in a computation-friendly format; it is hard to model what we do not know. The
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lack of computational legal ontologies makes it difficult to communicate in this research area
and slows the development of incremental knowledge. Open-ended legal statements, legal
contradictions, and unsettled areas of the law (e.g., federalism, evolving case law) present
additional challenges. Computational legal analysis is still a field in its infancy, and basic
research is needed to establish the buildings blocks that must undergird future developments.
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